MENU
+Compare
ACLX
Stock ticker: NASDAQ
AS OF
Nov 13, 04:22 PM (EDT)
Price
$87.11
Change
-$3.03 (-3.36%)
Capitalization
5.21B

ACLX Arcellx Forecast, Technical & Fundamental Analysis

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

ACLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ACLX with price predictions
Nov 12, 2025

Aroon Indicator for ACLX shows an upward move is likely

ACLX's Aroon Indicator triggered a bullish signal on October 27, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 130 similar instances where the Aroon Indicator showed a similar pattern. In of the 130 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 42 cases where ACLX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on ACLX as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACLX advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ACLX moved out of overbought territory on October 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for ACLX turned negative on October 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACLX broke above its upper Bollinger Band on October 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.820) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (138.889) is also within normal values, averaging (322.723).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACLX is expected to report earnings to fall 10.98% to -88 cents per share on February 26

Arcellx ACLX Stock Earnings Reports
Q4'25
Est.
$-0.88
Q3'25
Missed
by $0.03
Q2'25
Beat
by $0.08
Q1'25
Missed
by $0.37
Q4'24
Missed
by $0.31
The last earnings report on November 05 showed earnings per share of -99 cents, missing the estimate of -95 cents. With 341.38K shares outstanding, the current market capitalization sits at 5.21B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
130
Web
https://www.arcellx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRINX56.290.23
+0.41%
Harbor International Administrative
SCWFX74.150.16
+0.22%
American Funds SMALLCAP World F1
NWHDX16.290.02
+0.12%
Nationwide Bailard Cogntv Val A
NRIAX22.43-0.03
-0.13%
Nuveen Real Asset Income A
SCQGX102.10-0.23
-0.22%
DWS Large Cap Focus Growth S

ACLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-0.09%
CGON - ACLX
56%
Loosely correlated
+1.47%
BEAM - ACLX
52%
Loosely correlated
-2.71%
ROIV - ACLX
51%
Loosely correlated
+2.01%
NUVL - ACLX
51%
Loosely correlated
+0.91%
XNCR - ACLX
50%
Loosely correlated
-3.23%
More